Source: Annual Congress 2009 - Drug effects in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Dummer, M. Epton, J. Cowan, J. Cook, R. Condliffe, E. Landhuis, A. Smith, R. Taylor (Dunedin, New Zealand). Predicting response to corticosteroid in COPD using exhaled nitric oxide. Eur Respir J 2009; 34: Suppl. 53, 2011

Member's Comments

No comment yet.

Related content which might interest you: Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Exhaled nitric oxide as a predictor of exacerbations of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004 Fractionated exhaled nitric oxide in COPD patients Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Exhaled nitric oxide and COPD Source: Eur Respir J 2010; 36: 692 Year: 2010 Levels of asthma control and exhaled nitric oxide Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Fractional exhaled nitric oxide is associated with more severe asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Effect of caffeine on exhaled nitric oxide measurements in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003 Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 429s Year: 2004 Exhaled nitric oxide in the assessment of asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 18s Year: 2007 The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 Early and late effect of acute bronchodilation on exhaled nitric oxide in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006